A novel cis-acting element in Her2 promoter regulated by Stat3 in mammary cancer cells

Biochemical and Biophysical Research Communications

Volumn 345, Issue 2, 2006, Pages 660-668

  Qian, Lu ^a   Chen, Liyong ^a   Shi, Ming ^a   Yu, Ming ^a   Jin, Baofeng ^b   Hu, Meiru ^a   Xia, Qing ^a   Zhang, Xueming ^b   Shen, Beifen ^a   Guo, Ning ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b State Key Laboratory of Pathogen and Biosecurity   (China)

Author keywords

Breast cancer cells; cis Acting element; Her2; Promoter; Stat3

Indexed keywords

CIS ACTING ELEMENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; STAT3 PROTEIN;

ARTICLE; BINDING SITE; BREAST CANCER; CANCER CELL; CELL STIMULATION; CELL STRAIN MCF 7; DEFENSE MECHANISM; DNA SEQUENCE; GENE CONTROL; GENE DELETION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; SEQUENCE ANALYSIS;

BASE SEQUENCE; BINDING SITES; BREAST NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ERBB-2; GENES, REPORTER; HUMANS; MICROCHIP ANALYTICAL PROCEDURES; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; STAT3 TRANSCRIPTION FACTOR; TUMOR CELLS, CULTURED;

EID: 33646848776     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.04.153     Document Type: Article

References (45)

1. King C.R., Swain S.M., Porter L., Steinberg S.M., Lippman M.E., and Gelmann E.P. Heterogeneous expression of erbB-2 messenger RNA in human breast cancer. Cancer Res. 49 (1989) 4185-4191
2. Slamon D.J., Clark G.M., Wong S.G., Levin W.J., Ullrich A., and McGuire W.L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235 (1987) 177-182
3. Parkes H.C., Lillycrop K., Howell A., and Craig R.K. C-erbB2 mRNA expression in human breast tumours: comparison with c-erbB2 DNA amplification and correlation with prognosis. Br. J. Cancer 61 (1990) 39-45
4. Slamon D.J., Godolphin W., Jones L.A., Holt J.A., Wong S.G., Keith D.E., Levin W.J., Stuart S.G., Udove J., and Ullrich A. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244 (1989) 707-712
5. Tal M., King C.R., Kraus M.H., Ullrich A., Schlessinger J., and Givol D. Human HER2 (neu) promoter: evidence for multiple mechanisms for transcriptional initiation. Mol. Cell Biol. 7 (1987) 2597-2601
6. Chen Y., and Gill G.N. Positive and negative regulatory elements in the human erbB-2 gene promoter. Oncogene 9 (1994) 2269-2276
7. Chen Y., and Gill G.N. A heterodimeric nuclear protein complex binds two palindromic sequences in the proximal enhancer of the human erbB-2 gene. J. Biol. Chem. 271 (1996) 5183-5188
8. Grooteclaes M., Pasleau F., Dijkmans H., Berzi P., Albert A., and Winkler-Gol R. The 6-kilobase c-erbB2 promoter contains positive and negative regulatory elements functional in human mammary cell lines. Cancer Res. 54 (1994) 4193-4199
9. Scott G.K., Chang C.H., Erny K.M., Xu F., Fredericks W.J., Rauscher III F.J., Thor A.D., and Benz C.C. Ets regulation of the erbB2 promoter. Oncogene 19 (2000) 6490-6502
10. Bosher J.M., Williams T., and Hurst H.C. The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proc. Natl. Acad. Sci. USA 92 (1995) 744-747
11. Hollywood D.P., and Hurst H.C. A novel transcription factor, OB2-1, is required for overexpression of the proto-oncogene c-erbB-2 in mammary tumour lines. EMBO J. 12 (1993) 2369-2375
12. Vernimmen D., Begon D., Salvador C., Gofflot S., Grooteclaes M., and Winkler R. Identification of HTF (HER2 transcription factor) as an AP-2 (activator protein-2) transcription factor and contribution of the HTF binding site to ERBB2 gene overexpression. Biochem. J. 307 (2003) 323-329
13. Chen Y., Fischer W.H., and Gill G.N. Regulation of the ERBB-2 promoter by RBPJkappa and NOTCH. J. Biol. Chem. 272 (1997) 14110-14114
14. Benz C.C., O' Hagan R.C., Richter B., Scott G.K., Chang C.H., Xiong X., Chew K., Ljung B.M., Edgerton S., Thor A., and Hassell J.A. HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer. Oncogene 25 (1997) 1513-1525
15. Lohrisch C., and Piccart M. An overview of HER2. Semin. Oncol. 28 (2001) 3-11
16. Yarden Y. Biology of HER2 and its importance in breast cancer. Oncology 61 (2001) 1-13
17. Kokai Y., Cohen J.A., Drebin J.A., and Greene M.I. Stage- and tissue-specific expression of the neu oncogene in rat development. Proc. Natl. Acad. Sci. USA 84 (1987) 8498-8501
18. Quirke P., Pickles A., Tuzi N.L., Mohamdee O., and Gullick W.J. Pattern of expression of c-erbB-2 oncoprotein in human fetuses. Br. J. Cancer 60 (1989) 64-69
19. Grooteclaes M., Vernimmen D., Plaza S., Pasleau F., Hodzic D., and Winkler-Gol R. A new cis element is involved in the HER2 gene overexpression in human breast cancer cells. Cancer Res. 59 (1999) 2527-2531
20. Bromberg J.F., Wrzeszczynska M.H., Devgan G., Zhao Y., Pestell R.G., Albanese C., and Darnell J.E. Stat3 as an oncogene. Cell 98 (1999) 295-303
21. Dignam J.D., Lebovitz R.M., and Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11 (1983) 1475-1489
22. White M.R., and Hung M.C. Cloning and characterization of the mouse neu promoter. Oncogene 7 (1992) 677-683
23. Niu G., Wright K.L., Ma Y., Wright G.M., Huang M., Irby R., Briggs J., Karras J., Cress W.D., Pardoll D., Jove R., Chen J., and Yu H. Role of Stat3 in regulating p53 expression and function. Mol. Cell Biol. 25 (2005) 7432-7440
24. Park S., Kim D., Kaneko S., Szewczyk K.M., Nicosia S.V., Yu H., Jove R., and Cheng J.Q. Molecular cloning and characterization of the human AKT1 promoter uncovers its up-regulation by the Src/Stat3 pathway. J. Biol. Chem. 280 (2005) 38932-38941
25. Seidel H.M., Milocco L.H., Lamb P., Darnell J.E., Stein R.B., and Rosen J. Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc. Natl. Acad. Sci. USA 92 (1995) 3041-3045
26. Ehret G.B., Reichenbach P., Schindler U., Horvath C.M., Fritz S., Nabholz M., and Bucher P. DNA binding specificity of different STAT proteins. Comparison of in vitro specificity with natural target sites. J. Biol. Chem. 276 (2001) 6675-6688
27. O'Farrell A.M., Parry D.A., Zindy F., Roussel M.F., Lees E., Moore K.W., and Mui A.L. Stat3-dependent induction of p19INK4D by IL-10 contributes to inhibition of macrophage proliferation. J. Immunol. 164 (2000) 4607-4615
28. Bowman T., Garcia R., Turkson J., and Jove R. STATs in oncogenesis. Oncogene 19 (2000) 2474-2488
29. Calo V., Migliavacca M., Bazan V., Macaluso M., Buscemi M., Gebbia N., and Russo A. STAT proteins: from normal control of cellular events to tumorigenesis. J. Cell Physiol. 197 (2003) 157-168
30. Bromberg J., and Darnell J.E. The role of STATs in transcriptional control and their impact on cellular function. Oncogene 19 (2000) 2468-2473
31. Horvath C.M. STAT proteins and transcriptional responses to extracellular signals. Trends Biochem. Sci. 25 (2000) 496-502
32. Groner B., and Hennighausen L. Linear and cooperative signaling: roles for Stat proteins in the regulation of cell survival and apoptosis in the mammary epithelium. Breast Cancer Res. 2 (2000) 149-153
33. Amorino G.P., Hamilton V.M., Valerie K., Dent P., Lammering G., and Schmidt-Ullrich R.K. Epidermal growth factor receptor dependence of radiation-induced transcription factor activation in human breast carcinoma cells. Mol. Biol. Cell 13 (2002) 2233-2244
34. Chen H., Ye D., Xie X., Chen B., and Lu W. VEGF, VEGFRs expressions and activated STATs in ovarian epithelial carcinoma. Gynecol. Oncol. 94 (2004) 630-635
35. Berclaz G., Altermatt H.J., Rohrbach V., Siragusa A., Dreher E., and Smith P.D. EGFR dependent expression of STAT3 (but not STAT1) in breast cancer. Int. J. Oncol. 19 (2001) 1155-1160
36. Calo V., Migliavacca M., Bazan V., Macaluso M., Buscemi M., Gebbia N., and Russo A. STAT proteins: from normal control of cellular events to tumorigenesis. J. Cell Physiol. 197 (2003) 157-168
37. Levy D.E., and Lee C.K. What does Stat3 do?. J. Clin. Invest. 109 (2002) 1143-1148
38. Yan D.H., and Hung M.C. Identification and characterization of a novel enhancer for the rat neu promoter. Mol. Cell Biol. 11 (1991) 1875-1882
39. Carey M., and Smale S.T. Transcriptional Regulation in Eukaryotes: Concepts, Strategies, and Techniques (2001), Cold Spring Harbor, NY
40. Lewis B.A., and Reinberg D. The mediator coactivator complex: functional and physical roles in transcriptional regulation. J. Cell Sci. 116 (2003) 3667-3675
41. Bromberg J. Signal transducers and activators of transcription as regulators of growth, apoptosis and breast development. Breast Cancer Res. 2 (2000) 86-90
42. Niu G., Wright K.L., Huang M., Song L., Haura E., Turkson J., Zhang S., Wang T., Sinibaldi D., Coppola D., Heller R., Ellis L.M., Karras J., Bromberg J., Pardoll D., Jove R., and Yu H. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21 (2002) 2000-2008
43. Chapman R.S., Lourenco P., Tonner E., Flint D., Selbert S., Takeda K., Akira S., Clarke A.R., and Watson C.J. The role of Stat3 in apoptosis and mammary gland involution. Conditional deletion of Stat3. Adv. Exp. Med. Biol. 480 (2000) 129-138
44. Ren Z., and Schaefer T.S. ErbB-2 activates Stat3 alpha in a Src- and JAK2-dependent manner. J. Biol. Chem. 277 (2002) 38486-38493
45. Fernandes A., Hamburger A.W., and Gerwin B.I. ErbB-2 kinase is required for constitutive stat 3 activation in malignant human lung epithelial cells. Int. J. Cancer 83 (1999) 564-570